Edition:
United States

Photocure ASA (PHO.OL)

PHO.OL on Oslo Stock Exchange

26.70NOK
22 Nov 2017
Change (% chg)

-- (--)
Prev Close
kr26.70
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
112,970
52-wk High
kr51.25
52-wk Low
kr21.50

Chart for

About

Photocure ASA is a Norway-based company active in the pharmaceutical industry. It operates in the field of photodynamic diagnosis, cosmetics and treatment of acne, bladder cancer, colon cancer, as well as human papilloma virus (HPV) and precancerous lesions of the cervix. The Company’s activities comprise research, development... (more)

Overall

Beta: 0.49
Market Cap(Mil.): kr575.60
Shares Outstanding(Mil.): 21.56
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.69 15.46
EPS (TTM): -- -- --
ROI: -- 15.18 11.85
ROE: -- 16.59 15.83

BRIEF-Photocure Q3 EBITDA recurring loss widens to NOK 9.6 mln

* Q3 TOTAL REVENUES OF NOK ‍35.6​ MILLION VERSUS NOK 35.2 MILLION YEAR AGO

Nov 08 2017

BRIEF-FDA grants priority review for Photocure's Cysview sNDA

* REG-PHOTOCURE ASA: FDA GRANTS PRIORITY REVIEW FOR CYSVIEW® SUPPLEMENTAL NEW DRUG APPLICATION (SNDA)

Oct 18 2017

Earnings vs. Estimates